Subsidy

PLI Scheme for Bulk Drug Manufacturing 2025 – New Subsidy Guidelines

by
PLI Scheme for Bulk Drug Manufacturing 2025 – New Subsidy Guidelines

The Government of India has updated the Bulk Drug Production Linked Incentive Scheme 2025, providing revised subsidies and guidelines for the manufacturing of critical Active Pharmaceutical Ingredients (APIs) within the country. This initiative supports the “Atmanirbhar Bharat” mission by reducing import dependency and boosting local pharmaceutical manufacturing. With the 2025 update, the scheme offers more … Read more

Bulk Drug Park Scheme – June 2025 Subsidy and State-wise Allocation

by
Bulk Drug Park Scheme – June 2025 Subsidy and State-wise Allocation

The Government of India has released a major update in June 2025 regarding its ambitious Bulk Drug Park Scheme, a cornerstone of India’s pharmaceutical self-reliance strategy. Under this scheme, the government has sanctioned fresh subsidy allocations to three key states to accelerate the production of Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and intermediates. … Read more